| Pharmaceutical active ingredients: |
| ChlorquinaldolFluprednidene AcetateNystatin |
| Available forms, composition and doses of Candio E: |
| N / A |
| Candio E medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07CB02 - Fluprednidene and antibioticsG01AC03 - Chlorquinaldol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| BootsHermal Kurt Herrmann |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Temetex Compositum | Chlorquinaldol; Diflucortolone Valerate | Roche |
| Eczecur | Chlorquinaldol; Fluocortolone Caproate; Fluocortolone Pivalate | Bayer Schering Pharma |
| Ultraquinol | Chlorquinaldol; Fluocortolone Caproate; Fluocortolone Pivalate | Bayer Schering Pharma |
| Proctocort | Chlorquinaldol; Fluocortolone Caproate; Fluocortolone Pivalate; Pramoxine Hydrochloride; Troxerutin | Bayer Schering Pharma |
| Vobaderm Plus | Chlorquinaldol; Fluprednidene Acetate | Hermal Kurt Herrmann |
| Sterosan-Hydrocortisone | Chlorquinaldol; Hydrocortisone | Novartis |
| Cortikinol | Chlorquinaldol; Hydrocortisone Acetate | Nycomed |
| Locoid C | Chlorquinaldol; Hydrocortisone Butyrate | Astellas Pharma; 3M; CSL; Yamanouchi |
| Locoidol | Chlorquinaldol; Hydrocortisone Butyrate | Yamanouchi |
| Sano-Angin | Chlorquinaldol; Lidocaine Hydrochloride | Amino, Switzerland |